Atherosclerosis: Another protein misfolding disease?

Trends in Molecular Medicine

Volumn 8, Issue 8, 2002, Pages 370-374

  Ursini, Fulvio ^a   Davies, Kelvin J A ^b   Maiorino, Matilde ^a   Parasassi, Tiziana ^c   Sevanian, Alex ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CNR   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CYTOTOXICITY; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MOLECULAR DYNAMICS; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 0036317131     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02382-1     Document Type: Review

References (51)

1. Protein folding: Progress made and promises ahead
2. The cellular response to unfolded proteins: Inter-compartmental signaling
3. Lectins as chaperones in glycoprotein folding
4. A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response
5. Posttrauslational quality control: Folding, refolding and degrading proteins
6. The genetics of amyloidoses
7. Protein misfolding, evolution and disease
8. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
9. Protein damage and degradation by oxygen radicals: III. Modification of secondary and tertiary structure
10. Age-related changes in protein oxidation and proteolysis in mammalian cells
11. The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils
12. Degradation of oxidized proteins by the 20S proteasome
13. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease
14. Insulin-degrading enzyme: Embarking on amyloid destruction
15. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme
16. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: Potential role in oxidized LDL-induced apoptosis
17. Oxidized low-density lipoprotein-mediated toxicity to macrophages is mediated through lysosomal damage
18. Structure of apolipoprotein B-100 in low density lipoproteins
19. Translocation efficiency, susceptibility to proteosomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains
20. Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL
21. Temperature dependence of the optical activity of human serum low density lipoprotein. The role of lipids
22. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoprotein (LDL)
23. Lipid peroxidation in membranes and low-density lipoproteins: Similarities and differences
24. Core lipid structure is a major determinant of the oxidative resistance of low density lipoprotein
25. Surface-core relationships in human low desnity lipoprotein as studied by infrared spectroscopy
26. Altered phospholipid-apoB-100 interactions and generation of extra membrane material in proteolysis-induced fusion of LDL particles
27. Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation
28. The role of oxidized lipoproteins in atherogenesis
29. Atherosclerosis
30. Induction of NADPH cytochrome P450 reductase by theAlzheimer beta-protein. Amyloid as a foreign body
31. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: Reaction pathways and antioxidant protection
32. Crosslinking between low density lipoprotein ApoB and hemoglobin mediates conversion to electronegative LDL during the ex vivo blood circulation
33. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: Antioxidant role of haptoglobin
34. Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals
35. Protein modification by oxidants and the role of proteolytic enzymes
36. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation
37. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations
38. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
39. Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and CIII genes
40. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control
41. Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation
42. Oxidative modification of low-density lipoprotein (LDL) in HD patients: Role in electronegative LDL formation
43. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids
44. Postprandial oxidative stress
45. Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: A possible mechanism of smoking-related atherosclerosis
46. Hypochlorite induces the formation of LDL-, a potentially atherogenic low density lipoprotein subspecies
47. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL
48. LDL is a lipid hydroperoxide-enriched circulating lipoprotein
49. Loss of apoB-100 secondary structure and conformation in electronegative LDL (LDL-)
50. Secretory phospholipaseA2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins
51. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells